✓a pan-PIM2 inhibitor with Ki of 1.0 pM for PIM1, 2.1 pM for PIM2, and 0.8 pM for PIM3 [267]✓reduces p-RPS6 (S235/236) in multiple myeloma cells [132]. Here, PIM3 is linked to plasma cell myeloma.